319 related articles for article (PubMed ID: 22448150)
1. CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
; Young J; Psichogiou M; Meyer L; Ayayi S; Grabar S; Raffi F; Reiss P; Gazzard B; Sharland M; Gutierrez F; Obel N; Kirk O; Miro JM; Furrer H; Castagna A; De Wit S; Muñoz J; Kjaer J; Grarup J; Chêne G; Bucher H
PLoS Med; 2012; 9(3):e1001194. PubMed ID: 22448150
[TBL] [Abstract][Full Text] [Related]
2. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
[TBL] [Abstract][Full Text] [Related]
3. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
Wolbers M; Babiker A; Sabin C; Young J; Dorrucci M; Chêne G; Mussini C; Porter K; Bucher HC;
PLoS Med; 2010 Feb; 7(2):e1000239. PubMed ID: 20186270
[TBL] [Abstract][Full Text] [Related]
5. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery.
Engsig FN; Zangerle R; Katsarou O; Dabis F; Reiss P; Gill J; Porter K; Sabin C; Riordan A; Fätkenheuer G; Gutiérrez F; Raffi F; Kirk O; Mary-Krause M; Stephan C; de Olalla PG; Guest J; Samji H; Castagna A; d'Arminio Monforte A; Skaletz-Rorowski A; Ramos J; Lapadula G; Mussini C; Force L; Meyer L; Lampe F; Boufassa F; Bucher HC; De Wit S; Burkholder GA; Teira R; Justice AC; Sterling TR; M Crane H; Gerstoft J; Grarup J; May M; Chêne G; Ingle SM; Sterne J; Obel N;
Clin Infect Dis; 2014 May; 58(9):1312-21. PubMed ID: 24457342
[TBL] [Abstract][Full Text] [Related]
6. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Ledergerber B; Lundgren JD; Walker AS; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; Gill MJ; Castelli F; Phillips AN;
Lancet; 2004 Jul 3-9; 364(9428):51-62. PubMed ID: 15234856
[TBL] [Abstract][Full Text] [Related]
7. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements.
; Lanoy E; May M; Mocroft A; Phillip A; Justice A; Chêne G; Furrer H; Sterling T; Monforte AD; Force L; Gill J; Harris R; Hogg RS; Rockstroh J; Saag M; Khaykin P; de Wolf F; Sterne JA; Costagliola D
AIDS; 2009 Oct; 23(16):2199-208. PubMed ID: 19779320
[TBL] [Abstract][Full Text] [Related]
10. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
[TBL] [Abstract][Full Text] [Related]
11. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
12. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study.
Lee JS; Humes E; Hogan BC; Justice AC; Klein M; Gebo K; John Gill M; Silverberg MJ; Rebeiro P; Horberg M; Karris M; Rabkin C; Moore RD; Althoff KN;
Lancet HIV; 2022 Mar; 9 Suppl 1():S2. PubMed ID: 35304844
[TBL] [Abstract][Full Text] [Related]
13. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.
Mocroft A; Furrer HJ; Miro JM; Reiss P; Mussini C; Kirk O; Abgrall S; Ayayi S; Bartmeyer B; Braun D; Castagna A; d'Arminio Monforte A; Gazzard B; Gutierrez F; Hurtado I; Jansen K; Meyer L; Muñoz P; Obel N; Soler-Palacin P; Papadopoulos A; Raffi F; Ramos JT; Rockstroh JK; Salmon D; Torti C; Warszawski J; de Wit S; Zangerle R; Fabre-Colin C; Kjaer J; Chene G; Grarup J; Lundgren JD;
Clin Infect Dis; 2013 Oct; 57(7):1038-47. PubMed ID: 23921881
[TBL] [Abstract][Full Text] [Related]
14. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
16. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
Bouteloup V; Sabin C; Mocroft A; Gras L; Pantazis N; Le Moing V; d'Arminio Monforte A; Mary-Krause M; Roca B; Miro JM; Battegay M; Brockmeyer N; Berenguer J; Morlat P; Obel N; De Wit S; Fätkenheuer G; Zangerle R; Ghosn J; Pérez-Hoyos S; Campbell M; Prins M; Chêne G; Meyer L; Dorrucci M; Torti C; Thiébaut R;
HIV Med; 2017 Jan; 18(1):33-44. PubMed ID: 27625009
[TBL] [Abstract][Full Text] [Related]
17. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
[TBL] [Abstract][Full Text] [Related]
18. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
19. Higher risk of AIDS or death in patients with lower CD4 cell counts after virally suppressive HAART.
Taiwo BO; Li X; Palella F; Jacobson LP; Margolick JB; Detels R; Rinaldo CR; Phair JP
HIV Med; 2009 Nov; 10(10):657-60. PubMed ID: 19601997
[TBL] [Abstract][Full Text] [Related]
20. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
; Sterne JA; May M; Costagliola D; de Wolf F; Phillips AN; Harris R; Funk MJ; Geskus RB; Gill J; Dabis F; Miró JM; Justice AC; Ledergerber B; Fätkenheuer G; Hogg RS; Monforte AD; Saag M; Smith C; Staszewski S; Egger M; Cole SR
Lancet; 2009 Apr; 373(9672):1352-63. PubMed ID: 19361855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
